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Abstract Increased expression of low voltage-activated, T-type
Ca2+ channels has been correlated with a variety of cellular
events including cell proliferation and cell cycle kinetics. The
recent cloning of three genes encoding T-type K1 subunits, K1G,
K1H and K1I, now allows direct assessment of their involvement in
mediating cellular proliferation. By overexpressing the human
K1G and K1H subunits in human embryonic kidney (HEK-293)
cells, we describe here that, although T-type channels mediate
increases in intracellular Ca2+ concentrations, there is no
significant change in bromodeoxyuridine incorporation and flow
cytometric analysis. These results demonstrate that expressions
of T-type Ca2+ channels are not sufficient to modulate cellular
proliferation of HEK-293 cells. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
T-type Ca2 channels (T-channels) are preferentially ex-
pressed at foetal and early developmental stages of neuronal
and muscle cells [1^4] and a high level of T-channel expression
is observed in early mouse embryos [5] and blastocyst-derived
embryonic stem cells [6]. In cultured smooth muscle cells, it
has been described that the expression of T-channels is tran-
sient and parallels cell proliferation [7]. Recently, combined
patch-clamp and immunocytochemistry techniques have
shown a correlation between functional T-channels and the
presence of speci¢c markers of the cell cycle, both in cultured
smooth muscle cells [8] and in cardiomyocytes [9]. Similarly,
many proliferating cell lines exhibit large T-type current
(ICa;T) [10,11]. However, the fundamental question of whether
a rise in T-channel expression is a trigger or a consequence of
cell proliferation still remains. The use of mibefradil, a T-
channel blocker, has suggested that ICa;T is a trigger of cellular
proliferation [12]. Unfortunately, mibefradil is not a speci¢c
blocker of T-channels since it a¡ects high voltage-activated
Ca2 channels and other ionic channels [13], or even cyto-
chrome P-450 [14]. Consequently, proof that T-channels me-
diate proliferation may be provided by the manipulation of T-
channel expression in proliferating cells since several K1 sub-
units encoding T-channels have been cloned [4,15^19].
In the present study, we have examined whether overexpres-
sion of T-channels generated by the human K1G and K1H sub-
units modulates proliferation and cell cycle kinetics of the
human embryonic kidney (HEK-293) cell line. Functional ex-
pression studies in this cell line have already been used suc-
cessfully to study proliferation [20^22], as well as Ca2 chan-
nel-dependent gene expression [23]. Recently, it was shown
that recombinant T-channels generated by the K1G and K1H
subunits exhibit in HEK-293 cells similar properties to those
described in native cells [4,16]. We describe here that func-
tional expression of T-channels, which increases basal intra-
cellular Ca2 concentration, does not induce any change in
proliferation and cell cycle kinetics.
2. Materials and methods
2.1. Cell culture, transfection and isolation of cell lines
Twenty-four hours before transfection, HEK-293 cells were plated
at 70^90% con£uence in 35-mm dishes (Nunc) and grown in Dulbec-
co’s modi¢ed Eagle’s medium (Eurobio) supplemented with 10% foe-
tal bovine serum (Eurobio) and 1% penicillin^streptomycin (Gibco).
A human K1G cDNA (K1Gÿb [4]) subcloned into pBK-CMV vector
(Stratagene), as well as control pBK-CMV and pcDNA3 vectors, were
transfected using the standard calcium phosphate procedure. To es-
tablish cell lines, 1 mg/ml G418 (Life Technologies) was added to the
culture medium 48 h after transfection. After 7^10 days of G418
treatment, cells transfected with the pBK-CMV-K1G construct were
trypsinised and plated at a clonal density in a 96-well dish and ex-
panded. The resulting stable transfectants were screened for ICa;T with
electrophysiological techniques (see Section 2.2) and positive colonies
were maintained in G418 selection. Construction of the stable HEK-
293 cell line, AH13, which overexpressed the human K1H (pcDNA3-
K1H) was described previously [16]. In order to doublecheck the role
of the backbone vectors, the cDNA encoding K1H was also subcloned
into the pBK-CMV vector. In transient transfection experiments, cells
were co-transfected with an expression vector encoding the green £uo-
rescent protein (GFP) directed to the plasma membrane (pBB14: a
generous gift from L.W. Enquist, [24,25]). GFP was used to monitor
the transfection e⁄ciency (70% in average) and to identify positive
cells in electrophysiological and Ca2 imaging experiments in which
the pBKCMV-K1H or pBKCMV-K1G constructs were cotransfected in
a 10:1 ratio with the GFP construct.
2.2. Electrophysiology
The recording of whole-cell currents in HEK-293 cells overexpress-
ing K1G and K1H channels and their analysis were achieved as de-
scribed elsewhere [4,16]. The extracellular solution contained (in
mM): 2 CaCl2, 160 TEACl and 10 HEPES (pH to 7.4 with TEAOH).
Pipettes made of borosilicate glass with a typical resistance of 1^2 M6
were ¢lled with an internal solution containing (in mM): 110 CsCl, 10
EGTA, 10 HEPES, 3 Mg-ATP and 0.6 Na-GTP (pH to 7.2 with
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CsOH). The resting membrane potential (RMP) of HEK-293 cells was
measured in whole-cell con¢guration immediately after breaking the
patch membrane with an external medium made of Locke bu¡er
containing (in mM): 140 NaCl, 5 KCl, 1.2 KH2PO4, 1.2 MgSO4,
2 CaCl2, 10 glucose and 10 HEPES (pH 7.2), and pipette ¢lled with
(in mM): 110 K-aspartate, 20 KCl, 8 NaCl, 1 MgCl2, 1 CaCl2,
10 EGTA, 10 HEPES, 4 Mg-ATP, 0.3 Tris^GTP and 14 creatine
phosphate (pH to 7.3 with KOH). In these experiments, the junction
potential was less than 3 mV. Activation and inactivation curves were
obtained using Boltzmann equations and the negative product of
these two curves generated a theoretical ‘window’ current described
earlier [4]. The results are presented as the mean þ S.E.M., and n is the
number of cells used.
2.3. Calcium imaging
Twenty-four hours after transfection, cells were trypsinised and
plated onto polyornithine-coated borosilicate chambers (lab-tek;
Nunc) and cultured for 24 h. For the measurement of intracellular
Ca2, cells were incubated with 2.5 WM of acetoxymethyl ester of the
dual-excitation ratiometric Ca2 sensitive indicator fura-2 (Molecular
Probes) at 37‡C in the dark for 30 min in Locke bu¡er. Cells were
then washed thoroughly in Locke bu¡er and mounted onto the stage
of an inverted microscope (Olympus IX70) equipped with epi£uores-
cence and interfaced with the MERLIN software (LSR, Cambridge,
UK) to a monochromator (Spectramaster) and a 12/14 bit frame
transfert rate digital camera (Astrocam). The MERLIN software
was also used to calculate the 340/380 £uorescence ratio (Rf). The
intensity for £uorescent light emission (V= 510 nM) using excitation
at 340 and 380 nm was monitored at the level of each single fura-2-
loaded cell of the ¢eld. Extracellular application of Locke bu¡er con-
taining various concentrations of KCl (5 and 40 mM, substituted with
NaCl), Ca2 (0, 2 and 5 mM, substituted with MgCl2), mibefradil (1
WM), nickel (NiCl2) and ATP (20 WM) was achieved using a gravity-
driven multiple perfusion system placed in the close proximity of the
cells studied. In order to estimate the intracellular Ca2 concentration
from ratio images, calibration of the fura-2 £uorescence was per-
formed in ionomycin-treated HEK-293 cells (10 WM) incubated in
the presence (5 mM) and in the absence (0 mM plus 10 mM
EGTA) of external Ca2. The estimated [Ca2]in was deduced from
the equation: [Ca2] = Kd(f380 min/f380 max)(Rf3Rfmin)/(Rfmax3Rf),
where Kd was 225 nM and Rfmin (0.5V0.6 range) and Rfmax
(1.4V1.6 range) are the Rf values when the dye is free of Ca2 (0
Ca2/EGTA) and saturated with Ca2 (5 mM Ca2), respectively.
Data are presented as mean þ S.E.M. and statistical analyses are per-
formed with the Student’s t-test.
2.4. Bromodeoxyuridine (BrdU) labeling
For BrdU labeling, stable cells were plated at 30% con£uence on
12-mm glass coverslips in 35-mm Petri dishes. After 48 h, 10 WM
BrdU (Roche) was added to the medium for 45 min. Control experi-
ments with 2 mM hydroxyurea (HU; Sigma) were performed using
non-transfected cells maintained for 48 h in the presence of HU and
treated with BrdU still in the presence of HU (+HU, Fig. 3) or just
after removal of HU (3HU, Fig. 3). BrdU-treated cells were rinsed
with phosphate-bu¡ered saline (PBS) and ¢xed at room temperature
for 5 min in a 3.7% formaldehyde solution (Sigma) and washed with
PBS. Cells were permeabilised using cold acetone for 30 s, washed
twice (H2O and PBS) and treated with 3 N HCl for 15 min. After
several washes with H20 and PBS, the blocking of non-speci¢c sites
was performed by incubating cells at 37‡C in a 1% PBS^bovine serum
albumin (BSA) solution for 30 min. Cells were then incubated for 30
min at 37‡C with a mouse anti-BrdU antibody (Amersham), washed
three times with PBS and incubated with a sheep anti-mouse biotinyl-
ated antibody (Amersham) at 1/100 dilution in PBS^BSA solution
during 50 min at 37‡C. After three PBS washes, cells were treated
for 30 min at 37‡C with a streptavidin Texas Red antibody (Amer-
sham) at 1/200 dilution in 1% PBS^BSA solution. Cells were ¢nally
washed (3U PBS and H2O), labeled for 1 min with Hoescht 33258
nuclear dye (Sigma) and the coverslips were mounted using Gel-
mount (Biomedia). Digital images were acquired on a microscope
(Leica) and analysed with Adobe Photoshop 4.0. The percentage of
proliferative cells was de¢ned as the ratio of BrdU and Hoescht-pos-
itive cells (taken in a minimum of 10 independent ¢elds). Results are
presented as the mean þ S.E.M. and n is the number of independent
transfections.
2.5. Flow cytometry
For this set of experiments HEK-293 cells were plated at 90% con-
£uence on 35-mm Petri dishes from an initial large scale culture 1 day
before transfection. Transfection was achieved using Fugene 6TR
(Roche) to avoid cell cycle modulation observed with Ca2 phosphate
transfection procedure. Twenty-four hours after the transfection, cells
were trypsinised from each 35-mm dish and redistributed on three 60-
mm dishes at low density (10% con£uence). After 3 days, cells were
collected by trypsinisation, pelleted and resuspended in PBS. Two
volumes of cold, absolute ethanol were added and the samples were
stored at 320‡C. For cell cycle analysis, cell samples were pelleted and
resuspended in staining solution (25 Wg/ml propidium iodide, 0.1% tri-
sodium citrate dihydrate, 100 Wg/ml RNAse A, 0.05 mM EDTA, 0.1%
Triton X-100). Samples were maintained at 4‡C for at least 2 h in the
dark prior to analysis. Flow cytometric analysis was performed using
a FACscan (Becton Dickinson Immunocytometry System) and ana-
lysed using Mod¢t LT software (Verity Software House). Data are
presented for each phase of the cell cycle as the mean þ S.E.M., and n
is the number of independent transfections used.
3. Results
Whole-cell recordings of ICa;T were performed to verify that
both K1G and K1H subunits led to functional expression of
recombinant T-channels in HEK-293 cells both in transient
and stable cell lines (Fig. 1). Fig. 1A,B present typical families
of fast inactivating ICa;T generated by recombinant K1G and
K1H channels, respectively, that were obtained on stable cell
lines. The averaged current^voltage relationships (Fig. 1C,D,
respectively) exemplify that these two subunits produce typical
low voltage-activated currents, as described recently [4,16].
Steady-state activation properties (Fig. 1E,F) were similar
both for K1G and K1H currents considering the potential for
half-activation (345.5 þ 1.2 mV, n = 10 and 347.7 þ 1 mV,
n = 10, respectively), while the potential for half-inactivation
(V0:5) was signi¢cantly di¡erent (P6 0.05, Student’s t-test) for
K1G (366 þ 0.6 mV, n = 6) and K1H (372.5 þ 0.4 mV, n = 6)
currents. Superimposition of steady-state activation and inac-
tivation curves revealed the existence of a window current
both for the K1G and K1H currents (Fig. 1E and F). When
plotted as a function of the membrane potential, the predicted
window currents for K1H and K1G channels peaked at 365 and
348 mV, respectively (Fig. 1G,H). The RMP of control
HEK-293 cells measured in Locke bu¡er was 335 þ 5 mV
(n = 11, not shown), with the more hyperpolarised cells having
a RMP around 350 mV (V30% of the cells). Altogether,
these electrophysiological data clearly indicated that HEK-
293 cells expressed functional recombinant T-channels and
suggested that these channels could contribute to a moderate
and constant Ca2 entry at the cell’s RMP.
We then investigated whether overexpression of recombi-
nant T-channels lead to detectable changes in intracellular
Ca2 concentration. HEK-293 cells were loaded with fura-2
and analysed as described in Section 2. A typical experiment
performed with control and K1H-transfected cells is presented
in Fig. 2A,B. External perfusion of Locke bu¡er containing
various Ca2 concentrations (0, 2 and 5 mM) induced signi¢-
cant changes in the intracellular Ca2 concentration in trans-
fected cells (99 þ 5, 125 þ 4 and 164 þ 11 nM, respectively,
n = 11) (Fig. 2B), but not in control HEK-293 cells (116 þ 2,
115 þ 2 and 119 þ 3 nM, respectively, n = 25). Although these
experiments indicate that signi¢cant variation of [Ca2]in can
be observed in the presence of physiological external Ca2
concentration (2 mM), we used a Locke medium containing
5 mM Ca2 which increases the driving force and thereby
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favours the detection of intracellular Ca2 variations in the
experiments described below. It should be noted that electro-
physiological experiments revealed that the switch from 2 to
5 mM of the external Ca2 concentration induced a 45% in-
crease in the current amplitude and a 4 mV shift in the
steady-state activation and inactivation (n = 8, not shown).
The combined analysis of cells recorded from ¢ve independent
transfections has clearly indicated that the basal intracellular
concentration of Ca2 ([Ca2]in) in K1H-transfected cells was
markedly reduced by the application of mibefradil (1 WM) as
well as by the removal of external Ca2 (Fig. 2C), while no
change was observed in control cells (Fig. 2D,E). Overall, cells
transiently transfected with K1H showed an average 340/380
ratio of £uorescence (R f340/f380) of 0.95 þ 0.03, correspond-
ing to an estimated [Ca2]in of 198 þ 25 nM (n = 24), which
was signi¢cantly higher (P = 0.003, unpaired Student’s t-test)
than the one recorded in control cells (0.81 þ 0.02, i.e.
[Ca2]in = 126 þ 14 nM, n = 56). In K1H-transfected cells, the
removal of external Ca2 was associated with a signi¢cant
decrease (P = 0.001, paired Student’s t-test) in the 340/380
Fig. 1. Electrophysiological properties of Ca2 currents (ICa;T) generated by K1G and K1H subunits. A and B: Representative whole-cell Ca2
currents recorded in a cell transfected with pBK-CMV-K1G and with pcDNA3-K1H, respectively. The current traces were obtained for 100-ms
depolarising pulses ranging from 390 to +50 mV, from a holding potential of 3110 mV. The maximum current activation is obtained for a de-
polarising pulse at 330 mV (arrow) in both experimental situations. C and D: Averaged current^voltage relationships for K1G current (n = 10)
and K1H current (n = 10), respectively. The maximum current amplitude for each depolarising step was measured from current traces as ob-
tained in (A) and (B). The current density was calculated by dividing the current amplitude by the cell capacitance and plotted versus the test
pulse value. E and F: Voltage-dependence of the activation and inactivation of K1G current and K1H current, respectively. Activation curves
(mK) were derived from the ¢t of the current^voltage curves as described in Section 2 (n = 10). Similarly, inactivation curves (hK), constructed
from standard recordings using 5 s prepulses to various depolarising Vm were ¢tted with a Boltzmann function (n = 6). Superimposed activation
and inactivation curves predicted a window current. G and H: Calculated window current obtained by multiplying the activation conductance
curve (mK) by the inactivation curve (hK) for K1G current (G) and K1H current (H), respectively. Considering the density of Ca2 currents ob-
tained in K1H and K1G expressing cells, the maximum window current density is 0.34 and 0.27 pA/pF, respectively.
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ratio, from 0.95 þ 0.02 to 0.77 þ 0.01, i.e. 49% decrease in
[Ca2]in from 198 þ 25 to 101 þ 14 nM (n = 24), but not in
control cells ([Ca2]in ; 126 þ 14 and 120 þ 14 nM (n = 56), in
5 and 0 mM Ca2, respectively) (Fig. 2E). Basal [Ca2]in in
K1H-transfected cells was also strongly a¡ected by Ni2 con-
centrations as low as 5 WM (Fig. 2F), while in control cells no
change in basal [Ca2]in was observed even in the presence of
300 WM Ni2 (Fig. 2G). In addition, perfusion of 40 mM KCl
Fig. 2. Changes in [Ca2]in observed in HEK-293 cells overexpressing the K1H subunit. A: K1H-overexpressing (bold line, average of six cells)
and control (normal line, average of ¢ve cells) cells were loaded with fura-2 and examined for their variation in [Ca2]in according to the ratio
of £uorescence at 340 and 380 nm (R f340/f380) during perfusion of Locke medium containing 2, 5 and 0 mM Ca2. At the end of the experi-
ment an application of ATP (20 WM) indicated the level of responsiveness of the cells. B: Histogram of the corresponding values of the
[Ca2]in for control (white bar, n = 25) and K1H-overexpressing cells (black bars, n = 11) in 2, 5 and 0 mM Ca2, as indicated in the ¢gure. The
changes in [Ca2]in that were signi¢cantly di¡erent at P = 0.001 (**) are indicated in the ¢gure. C: K1H-overexpressing cells were examined in
the presence of 5 mM external Ca2 following application of 1 WM mibefradil, removal of external Ca2 (0 Ca) and application of 40 mM
KCl, as indicated on the panel. The traces correspond to three individual cells. D: Average changes in [Ca2]in following application of 1 WM
mibefradil and removal of external Ca2 in control cells (average of ¢ve cells). E: Histogram representation of the changes in [Ca2]in following
removal of external Ca2 (white bars), compared to basal [Ca2]in (black bars) in K1H-transfected cells (left part, n = 24) and in control cells
(right part, n = 56). The change in [Ca2]in was signi¢cantly di¡erent at P = 0.005 (*) between control (5 mM Ca2) and 0 mM Ca2 for K1H-
transfected cells. F: Change in basal [Ca2]in following application of 5, 50 and 300 WM Ni2 in K1H-transfected cells (average of ¢ve cells
from one ¢eld). G: Similar experiment as in (D) on control cells (average of six cells from one ¢eld).
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which induces cell depolarisation also decreased the basal
[Ca2]in in transfected cells (Fig. 2C). Removal of external
Ca2 in these experimental conditions did not contribute to
an additional reduction of the basal [Ca2]in. Similar results
were obtained in cells transiently transfected with K1G subunit,
as well as for stable cell lines overexpressing K1G or K1H (not
shown). Altogether, these data indicate that T-channels con-
tribute to increase basal [Ca2]in, most likely due to the exis-
tence of a window current.
The identi¢cation of ICa;T and the concomitant evidence for
an increase in basal [Ca2]in in cells overexpressing K1H and
K1G subunits were important prerequisites for probing
whether the proliferation of HEK-293 cells overexpressing
T-type Ca2 channels was a¡ected. Using cell lines overex-
pressing the K1H and K1G subunits, we have performed
BrdU labeling. BrdU is a thymidine analog and its incorpo-
ration into DNA during short incubation (45 min) is a good
index of cell proliferation by identifying cells entering the S
phase [26]. Control experiments were performed with cells
incubated with 2 mM HU for 48 h which synchronises the
cells in the G1/S transition. When cells were maintained in the
presence of HU during BrdU incubation, no cell was BrdU
positive, while the removal of HU before BrdU incubation led
to 70% of the cells in S-phase. Nevertheless, no di¡erence was
observed between control HEK-293 cells (V40% in S-phase)
and the cell lines overexpressing K1H or K1G subunits or the
control vectors, pBK-CMV or pcDNA3, for their incorpora-
tion of BrdU (Fig. 3). In addition, BrdU incorporation after
HU synchronisation of K1H and K1G cell lines gave similar
results as for control cells suggesting that no change in the
cell cycle kinetics was induced in cells overexpressing T-chan-
nels (not shown).
Fig. 3. Identi¢cation of BrdU-positive cells in control cell lines and in cell lines overexpressing T-channels. A: Example of a ¢eld showing cell
nuclei stained with Hoescht 33258 (left panel) and BrdU (right panel). The staining procedures are described in Section 2. B: The bars
(mean þ S.E.M.) represent the percentage of BrdU positive cells obtained from several independent transfections (see n values below) in a varie-
ty of experimental situations. The experimental situations are labeled as follow: 3HU, HU is removed just before BrdU incubation in control
cells cultivated for 48 h in the presence of HU (n = 13); +HU, HU is kept during the BrdU (n = 24); Ctrl, control HEK-293 cells (n = 20);
+pBK-CMV, cell line established from HEK-293 cells transfected with the control vector (n = 22); +pcDNA3, cell line established from HEK-
293 cells transfected with the control vector (n = 12); +pBK-CMV-K1G, cell line established from HEK-293 cells transfected with the pBK-
CMV-K1G vector (n = 28); +pcDNA3-K1H, cell line established from HEK-293 cells transfected with the pcDNA3-K1H vector (n = 14).
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We then used £ow cytometry, a more speci¢c approach, to
detect whether overexpression of T-type calcium channels
would modify cell cycle kinetics. We have designed this set
of experiments using transiently transfected cells, whereas
BrdU experiments described above were conducted on stable
cell lines. Flow cytometric experiments were also performed
with cells (i) incubated for 48 h with nocodazole and (ii) cells
treated with HU following nocodazole treatment, to control
the G2/M and G0/G1 peak analysis treatment. The fraction of
cells in each phase of the cell cycle was then determined for
various experimental conditions (Fig. 4). The percentage of
control HEK-293 cells in G0/G1, S and G2M phases were
48.3 þ 1.1%, 31.8 þ 1% and 20 þ 0.5%, respectively. Similar re-
sults were obtained on the various samples of cells transfected
with K1H and K1G cDNAs, on control plasmid-transfected
cells, as well as on the stable transfected cell lines used above
(not shown). The results presented in Fig. 4 were obtained
from cells collected from at least 15 independent transfections.
Overall, no signi¢cant di¡erences in cell cycle activity were
obtained among the various experimental conditions.
4. Discussion
The major ¢nding of our study is that the functional ex-
pression of T-type Ca2 channels in the HEK-293 cell line
does not a¡ect either proliferation or cell cycle kinetics. The
data strongly suggest that the expression of T-channels by
itself does not trigger a generalised signal transduction path-
way that stimulates progression of the cell cycle. This study
also describes for the ¢rst time that the basal level of [Ca2]in
is increased in HEK-293 cells overexpressing T-channels. The
dependence to extracellular Ca2 ions and its sensitivity to
mibefradil [4,16] and Ni2 clearly indicate that T-type Ca2
channels are involved in the regulation of the basal level of
[Ca2]in. Overexpression of the K1H subunit was particularly
useful in this demonstration since K1H currents are blocked by
low concentration of Ni2 [27]. In addition, HEK-293 cells
that overexpress T-channels do not elicit any Ca2 transients
following 40 mM KCl depolarisation, but a decrease in the
basal level of [Ca2]in. Although the RMP of HEK-293 cells
covers a large range (350 to 320 mV), our data strongly
suggest that the increase in the basal level of [Ca2]in occurs
in association with the window current of T-channels. Re-
cently, Sutton et al. [23] demonstrated that overexpression
of P/Q-type Ca2 channels in HEK-293 cells can mediate an
elevation of resting [Ca2]in responsible for syntaxin-1A ex-
pression. Similarly, we suggest that T-channels play an impor-
tant role by tuning [Ca2]in and therefore could participate to
the regulation of Ca2-dependent pathways, including gene
expression.
The factors regulating the functional expression of T-type
Ca2 channels have yet to be identi¢ed. Beside de¢ning the
exact role of T-channels in cell cycle progression, it will be
important to identify the cell cycle-dependent pathways in-
volved in the functional expression of T-channels. These reg-
ulations could occur at speci¢c stages of development and
pathogenesis, and most probably are cell type-dependent.
The association of ICa;T with cellular proliferation is well
documented for vascular smooth muscle (VSM) myocytes
[7,8,28,29] and it will now be important to determine whether
the overexpression of T-channels in VSM cells modulate cell
proliferation. The data reported here have demonstrated that
basal [Ca2]in can depend on T-channel expression. This ob-
servation is important to consider since concomitant T-chan-
nel expression and Ca2 overload have been reported in car-
diovascular diseases, such as cardiac hypertrophy [30,31].
Further investigations should therefore combine manipulation
of T-channel expression, [Ca2]in measurements and analysis
of Ca2-dependent pathways to determine the role of T-chan-
nels in normal physiology as well as in pathogenesis.
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